Skip to main content

Peer Review reports

From: Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study

Original Submission
1 Dec 2023 Submitted Original manuscript
11 Dec 2023 Reviewed Reviewer Report
14 Dec 2023 Reviewed Reviewer Report
17 Dec 2023 Reviewed Reviewer Report
24 Dec 2023 Reviewed Reviewer Report
5 Jan 2024 Author responded Author comments - Riccardo Giossi
9 Jan 2024 Reviewed Reviewer Report
11 Jan 2024 Reviewed Reviewer Report
17 Jan 2024 Reviewed Reviewer Report
Resubmission - Version 2
5 Jan 2024 Submitted Manuscript version 2
Publishing
17 Jan 2024 Editorially accepted
2 Feb 2024 Article published 10.1186/s10194-024-01721-6

You can find further information about peer review here.

Back to article page